Ameritas Investment Partners’s Unity Biotechnology UBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-100
| Closed | -$6 | – | 3183 |
|
|
2025
Q3 | $6 | Hold |
100
| – | – | ﹤0.01% | 3143 |
|
|
2025
Q2 | $38 | Hold |
100
| – | – | ﹤0.01% | 3189 |
|
|
2025
Q1 | $104 | Hold |
100
| – | – | ﹤0.01% | 3127 |
|
|
2024
Q4 | $98 | Hold |
100
| – | – | ﹤0.01% | 3133 |
|
|
2024
Q3 | $147 | Hold |
100
| – | – | ﹤0.01% | 3124 |
|
|
2024
Q2 | $135 | Hold |
100
| – | – | ﹤0.01% | 3116 |
|
|
2024
Q1 | $164 | Hold |
100
| – | – | ﹤0.01% | 3057 |
|
|
2023
Q4 | $193 | Hold |
100
| – | – | ﹤0.01% | 3085 |
|
|
2023
Q3 | $240 | Hold |
100
| – | – | ﹤0.01% | 3098 |
|
|
2023
Q2 | $255 | Hold |
100
| – | – | ﹤0.01% | 3104 |
|
|
2023
Q1 | $163 | Hold |
100
| – | – | ﹤0.01% | 3000 |
|
|
2022
Q4 | $274 | Buy |
+100
| New | +$291 | ﹤0.01% | 3037 |
|
|
2022
Q2 | – | Sell |
-100
| Closed | -$1K | – | 3238 |
|
|
2022
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 3070 |
|
|
2021
Q4 | $1K | Buy |
+100
| New | +$2.19K | ﹤0.01% | 3103 |
|
|
2021
Q2 | – | Sell |
-291
| Closed | -$17K | – | 3229 |
|
|
2021
Q1 | $17K | Hold |
291
| – | – | ﹤0.01% | 2638 |
|
|
2020
Q4 | $15K | Hold |
291
| – | – | ﹤0.01% | 2623 |
|
|
2020
Q3 | $10K | Hold |
291
| – | – | ﹤0.01% | 2728 |
|
|
2020
Q2 | $25K | Buy |
291
+86
| +42% | +$6.38K | ﹤0.01% | 2241 |
|
|
2020
Q1 | $12K | Hold |
205
| – | – | ﹤0.01% | 2456 |
|
|
2019
Q4 | $15K | Hold |
205
| – | – | ﹤0.01% | 2566 |
|
|
2019
Q3 | $13K | Hold |
205
| – | – | ﹤0.01% | 2623 |
|
|
2019
Q2 | $20K | Hold |
205
| – | – | ﹤0.01% | 2446 |
|
|
2019
Q1 | $17K | Hold |
205
| – | – | ﹤0.01% | 2469 |
|
|
2018
Q4 | $33K | Buy |
205
+163
| +388% | +$21.6K | ﹤0.01% | 2048 |
|
|
2018
Q3 | $7K | Hold |
42
| – | – | ﹤0.01% | 2920 |
|
|
2018
Q2 | $6K | Buy |
+42
| New | +$6.14K | ﹤0.01% | 2924 |
|
Ameritas Investment Partners's UBX Position: Q4 2025 in Review
Ameritas Investment Partners sold out of Unity Biotechnology (UBX) in Q4 2025, closing a stake of 100 shares — an estimated $6 sold.
Ameritas Investment Partners first reported a position in UBX in Q2 2018 and held it in 26 quarters. The position peaked at $33K in Q4 2018. 0 funds tracked by Wall St. Rank hold UBX as of Q4 2025.
- Ameritas Investment Partners reported no remaining Unity Biotechnology position as of Q4 2025 after selling out during the quarter.
- Ameritas Investment Partners sold 100 Unity Biotechnology shares in Q4 2025, an estimated $6.
- Ameritas Investment Partners first reported a position in Unity Biotechnology in Q2 2018 and held it in 26 quarters.
- Ameritas Investment Partners's Unity Biotechnology position peaked at $33K in Q4 2018.
- 0 funds tracked by Wall St. Rank held Unity Biotechnology as of Q4 2025.
Based on Ameritas Investment Partners's 13F filing for Q4 2025, filed 11 Feb 2026.